We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Obesity and Goal-directed Intraoperative Fluid Therapy

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01052519
First Posted: January 20, 2010
Last Update Posted: November 19, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Barbara Kabon, Medical University of Vienna
  Purpose

The purpose of the study is to compare non-obese patients (BMI≤ 30 kg/m2)versus obese patients (BMI> 30 kg/m2) in regard of their respective needs for intraoperative fluid therapy during laparoscopic surgery.

Specifically the investigators will test the hypothesis that subcutaneous tissue oxygenation (PsqO2)is increased in obese patients when fluid management is optimized by means of esophageal Doppler monitoring compared to obese patients undergoing standard fluid management.

Furthermore the investigators will test the hypothesis that PsqO2 is decreased in obese patients undergoing conventional fluid therapy compared to non-obese patients when fluid management is optimized. Thus the investigators assume that PsqO2 is similar in obese and non-obese patients when fluid management is optimized in both groups.


Condition Intervention
Obesity Other: Goal directed fluid therapy

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Intraoperative Goal-directed Fluid Management in Non-Obese and Obese Patients Undergoing Laparoscopic Surgery

Further study details as provided by Barbara Kabon, Medical University of Vienna:

Primary Outcome Measures:
  • Subcutaneous tissue oxygenation [ Time Frame: intraoperative and 2 postoperative hours ]

Enrollment: 90
Study Start Date: January 2010
Study Completion Date: June 2014
Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
No Intervention: obese control
Active Comparator: obese goal-directed Other: Goal directed fluid therapy
Fluid will be administered to reach maximal stroke volume during the intraoperative period.
Active Comparator: non-obese goal directed Other: Goal directed fluid therapy
Fluid will be administered to reach maximal stroke volume during the intraoperative period.

Detailed Description:

Hemodynamic stability and normovolemia are critical determinants of tissue perfusion and oxygenation. Adequate tissue oxygenation is essential to maintain normal physiologic functions and to reduce complications, such as wound infections.

Fat tissue is relatively hypoperfused and, therefore, poorly oxygenated. Subcutaneous tissue oxygenation in the obese is thus critically low and even supplemental oxygen only slightly increases subcutaneous oxygenation.It is likely that poor subcutaneous oxygenation in the obese surgical patients results in part from inadequate intraoperative fluid replacement.

It remains unknown how to hydrate obese surgical patients best. The most physiologic approach for perioperative fluid replacement is now thought to be goal-directed management, using stroke volume as the treatment parameter.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Non-obese (BMI≤ 30kg/m2) and obese patients (BMI > 30 kg/m2)
  • undergoing laparoscopic elective fundoplication or elective bariatric surgery

Exclusion Criteria:

  • decompensate heart failure
  • documented coronary artery disease
  • renal insufficiency
  • severe chronic obstructive pulmonary disease
  • symptoms of infection or sepsis
  • esophageal disease (excepting gastro-esophageal reflux without any other esophageal alteration).
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01052519


Locations
Austria
Department of Anesthesiology, Medical University of Vienna
Vienna, Austria, A-1070
Sponsors and Collaborators
Medical University of Vienna
Investigators
Principal Investigator: Barbara Kabon, MD MUW
  More Information

Publications:
Responsible Party: Barbara Kabon, PD. MD., Medical University of Vienna
ClinicalTrials.gov Identifier: NCT01052519     History of Changes
Other Study ID Numbers: 708/2009, local IRB
First Submitted: January 19, 2010
First Posted: January 20, 2010
Last Update Posted: November 19, 2014
Last Verified: November 2014

Keywords provided by Barbara Kabon, Medical University of Vienna:
Obesity
Esophageal Doppler monitoring
tissue oxygen tension

Additional relevant MeSH terms:
Obesity
Overnutrition
Nutrition Disorders
Overweight
Body Weight
Signs and Symptoms